Veteran dermatology Physician Assistant Douglas DiRuggiero, PA-C, DMSc, shares practical insights on how he incorporates ZORYVE® (roflumilast) into the treatment of atopic dermatitis, seborrheic...
In this episode of Ask the Experts, dermatology Physician Assistant Douglas DiRuggiero, PA-C, DMSc, shares what's unique about the formulations of ZORYVE® (roflumilast). Mr. DiRuggiero discusses how...
In this video, dermatologist Steven Feldman, MD, PhD, speaks with allergist and immunologist Jason Caldwell, DO, and pediatric dermatologist Robert Sidbury, MD, MPH, about atopic dermatitis (AD), including...
In this video, dermatologist Steven Feldman, MD, PhD, speaks with allergist and immunologist Jason Caldwell, DO, and pediatric dermatologist Robert Sidbury, MD, MPH, about the multidisciplinary approach in...
In this video, Albert Rizzo, MD, speaks with allergist and immunologist Juanita Mora, MD, pediatrician John Harrington, MD, and pulmonary and critical care physician, David Hill, MD about updates to the...
In this episode, Dr Rizzo interviews Sally E. Wenzel, MD, to discuss her review titled “Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics,” examining comorbidities (including...
In this video, Jonathan Silverberg, MD, PhD, MPH, discusses his team's study, which found that lebrikizumab was highly effective in treating symptoms of moderate-to-severe atopic dermatitis in adults and...
In this video, Evgeny Berdyshev, PhD, lead author of the study, "Stratum Corneum Lipid and Cytokine Biomarkers at Two Months of Age Predict the Future Onset of Atopic Dermatitis" discusses how lipid and...
01/07/2024
Critical Observations in Pulmonary Medicine, Ep. 6
Critical Observations in Pulmonary Medicine, Ep. 6
In this episode, Albert Rizzo, MD, interviews Michael S. Blaiss, MD, to discuss allergic asthma and its comorbidities, including the definition, diagnosis, and management of patients with allergic asthma....
In this video, Amy S. Paller, MD, discusses the efficacy and safety of dupilumab for patients with erythrodermic atopic dermatitis (AD), what these results mean for patients with severe AD, and how her...
